TP10 soluble complement receptor 1: Completed patient accrual in Phase I testing of safety and pharmacokinetics, with results to be presented in October at the

T Cell Sciences Inc. (TCEL), Needham, Mass. Product: TP10 soluble complement receptor 1, an inhibitor of complement activation Indication: Adult respiratory distress syndrome Status: Completed patien...